Pages that link to "Q38282986"

The following pages link to The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer (Q38282986):

Displaying 47 items.

• Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast (Q24813750) (← links)
• Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis (Q26749393) (← links)
• Emerging critical role of molecular testing in diagnostic genitourinary pathology (Q27021371) (← links)
• Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa (Q28246673) (← links)
• Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer (Q33856008) (← links)
• Molecular Diagnostics in Urologic Malignancies: A Work in Progress (Q33884017) (← links)
• High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer (Q33903731) (← links)
• Novel approaches in the therapy of metastatic renal cell carcinoma. (Q34409187) (← links)
• Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma (Q35063395) (← links)
• Pathobiology and chemoprevention of bladder cancer (Q35219328) (← links)
• Microenvironmental and cellular consequences of altered blood flow in tumours (Q35904989) (← links)
• Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection (Q35926074) (← links)
• Molecular pathways in bladder cancer: part 2. (Q36037512) (← links)
• Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I. (Q36109653) (← links)
• Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. (Q36610569) (← links)
• Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression (Q36615803) (← links)
• Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome (Q36670928) (← links)
• Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells (Q37058320) (← links)
• The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. (Q37081132) (← links)
• Hypoxia in microscopic tumors. (Q37126963) (← links)
• Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies (Q37145167) (← links)
• The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder (Q37145181) (← links)
• New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation (Q37796596) (← links)
• Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? (Q37967115) (← links)
• Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers (Q38132855) (← links)
• Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer (Q38323014) (← links)
• Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer (Q38414507) (← links)
• Bioimaging of fluorescence-labeled mitochondria in subcutaneously grafted murine melanoma cells by the "in vivo cryotechnique". (Q38522162) (← links)
• Next revolution in molecular theranostics: personalized medicine for urologic cancers. (Q38559336) (← links)
• GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. (Q38602274) (← links)
• Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. (Q39137839) (← links)
• Exploiting the tumor microenvironment in the development of targeted cancer gene therapy (Q39935539) (← links)
• Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN). (Q40447356) (← links)
• Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer (Q42453016) (← links)
• Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (Q44366527) (← links)
• Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides (Q44624065) (← links)
• Carbonic anhydrase inhibitors. inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions (Q44704011) (← links)
• Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin (Q44756647) (← links)
• Lactate stimulates CA IX expression in normoxic cancer cells. (Q46269325) (← links)
• Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker (Q46541391) (← links)
• Antiangiogenic effects of recombinant human endostatin in lung cancers. (Q47370386) (← links)
• Molecular analysis of transitional cell carcinoma using cDNA microarray (Q47612069) (← links)
• Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma (Q57815591) (← links)
• Targeting Carbonic Anhydrases with Fluorescent BODIPY-Labelled Sulfonamides (Q58211551) (← links)
• The relation between hypoxia-inducible factor (HIF)-1α and HIF-2α expression with anemia and outcome in surgically treated head and neck cancer (Q58211909) (← links)
• Expression of carbonic anhydrase IX in genitourinary and adrenal tumours (Q82995248) (← links)
• Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments (Q85102344) (← links)